Nephrogenic systemic fibrosis: mini-review
Clinics, 2009 Juliano Sacramento Mundim +3 more
doaj +1 more source
Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review. [PDF]
Ann Intern Med, 2020 Lunyera J +15 more
europepmc +1 more source
Late Onset Nephrogenic Systemic Fibrosis in a Patient with Stage 3 Chronic Kidney Disease: a Case Report. [PDF]
J Korean Med Sci, 2020 Lim YJ +7 more
europepmc +1 more source
Systemic Sclerosis: The Role of YAP/TAZ in Disease Pathogenesis
European Medical Journal, 2019 Systemic sclerosis (SSc) is a systemic autoimmune condition of unknown cause. Yes-Associated Protein/Tafazzin (YAP/TAZ) are transcriptional coactivators previously demonstrated to be involved in cellular stretch biology, and form the principal effector ...
Thomas Walsh
doaj
Nephrogenic systemic fibrosis: the end of the story? [PDF]
Quant Imaging Med Surg, 2019 Malikova H.
europepmc +1 more source
The extra miles on preventing nephrogenic systemic fibrosis. [PDF]
Quant Imaging Med Surg, 2019 Kartamihardja AAP, Tsushima Y.
europepmc +1 more source
Nephrogenic Systemic Fibrosis Risk Assessment and Skin Biopsy Quantification in Patients with Renal Disease following Gadobenate Contrast Administration. [PDF]
AJNR Am J Neuroradiol, 2020 Kanal E, Patton TJ, Krefting I, Wang C.
europepmc +1 more source
Nephrogenic Systemic Fibrosis in Patients with Advanced Renal Dysfunction Following Gadolinium-based Contrast Agents. [PDF]
RadiologyMallepally A +7 more
europepmc +1 more source
10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016. [PDF]
Invest Radiol, 2018 Endrikat J +5 more
europepmc +1 more source
Contrast-induced acute kidney injury and nephrogenic systemic fibrosis in children. [PDF]
Pediatr NephrolChuah AM +4 more
europepmc +1 more source